AstraZeneca Plans Major Investments Observing the 70th anniversary of its presence in Taiwan, pharmaceutical giant AstraZeneca announced plans to invest an additional NT$1 billion (over US$32 million) here in the next three years. AstraZeneca Taiwan president Simon Manners said the company will launch 10 new medicines by 2021, three of which have received priority approval…

U.S.-China Trade War Draws Attention News reports indicate that at a number of Taiwanese firms are considering abandoning their Chinese production bases and returning to Taiwan to avoid being caught in the U.S.-China trade war. Although Taiwan has not been directly targeted by either country, many Taiwanese manufacturers have moved their production sites to China,…